| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) | 
|---|
| 03/29/2007 | WO2007006870A3 Novel carbohydrate profile compositions from human cells and methods for analysis and modification thereof | 
| 03/29/2007 | WO2006138225A3 A novel and practical serological assay for the clinical diagnosis of leishmaniasis | 
| 03/29/2007 | WO2006136953A3 Method of producing organotypic cell cultures | 
| 03/29/2007 | WO2006130651A3 Method of forming dendritic cells from embryonic stem cells | 
| 03/29/2007 | WO2006128100A3 Chondrogenic compositions and methods of use | 
| 03/29/2007 | WO2006128084A3 Trps1-mediated modulation of hair growth | 
| 03/29/2007 | WO2006116717A3 Autologous somatic cells from peripheral blood and uses thereof | 
| 03/29/2007 | WO2006111387A3 Mammalian expression vector comprising the mcmv promoter and first intron of hcmv major immediate early gene | 
| 03/29/2007 | WO2006086454A3 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms | 
| 03/29/2007 | WO2006057674A3 COMPOSITIONS AND METHODS FOR EX VIVO PRESERVATION OF BLOOD VESSELS FOR VASCULAR GRAFTS USING ANALOGUES OF cAMP AND cGMP | 
| 03/29/2007 | WO2005053811A3 Biomolecule partition motifs and uses thereof | 
| 03/29/2007 | WO2005042723A3 Novel multipotent stem cells and use thereof | 
| 03/29/2007 | WO2004081197A3 Immune response associated proteins | 
| 03/29/2007 | US20070074314 Vectors and methods for improved plant transformation efficiency | 
| 03/29/2007 | US20070074313 Native antibiotic resistance genes | 
| 03/29/2007 | US20070074312 Plants containing a heterologous flavohemoglobin gene and methods of use thereof | 
| 03/29/2007 | US20070074311 Compositions and methods for modulating expression of gene products | 
| 03/29/2007 | US20070074310 Plants synthesizing a modified starch, a process for the generation of the plants, their use, and the modified starch | 
| 03/29/2007 | US20070074309 Polypeptides and expression vectors host cell and transgenic plants with nucleic acid and stress resistance; antifungal agent | 
| 03/29/2007 | US20070074308 Useful in protecting plants from insect damage; also included are micro-organisms and plants transformed with DNA sequence encoding an insecticidal Cry1Bf protein to obtain a plant resistant to insects | 
| 03/29/2007 | US20070074307 Citrus tristeza virus resistance genes and methods of use | 
| 03/29/2007 | US20070074306 Plant transcriptional activator and uses thereof | 
| 03/29/2007 | US20070074305 nucleic acid molecule comprising a first nucleic acid segment encoding a polypeptide, and a second nucleic acid segment for suppression of a polypeptide involved in altering oleic acid content in a plant cell | 
| 03/29/2007 | US20070074302 Triticale cultivar 97TV38011 | 
| 03/29/2007 | US20070074299 Transgenic Mice Containing GPCR5-1 Gene Disruptions | 
| 03/29/2007 | US20070074298 Versican and epithelial-mesenchymal interaction | 
| 03/29/2007 | US20070074295 Schizophrenia related gene | 
| 03/29/2007 | US20070073048 Hiv polynucleotides and polypeptides derived from botswana mj4 | 
| 03/29/2007 | US20070073043 Process for producing humanized chimera antibody | 
| 03/29/2007 | US20070073041 Human tumor necrosis factor receptor polypeptides | 
| 03/29/2007 | US20070072801 Methods of treatment using specific binding agents of human angiopoietin-2 | 
| 03/29/2007 | US20070072794 Novel genes and proteins encoded thereby | 
| 03/29/2007 | US20070072296 C/EBPalpha gene targeting constructs and uses thereof | 
| 03/29/2007 | US20070072295 Multipotent lymphohematopoietic progenitor cells | 
| 03/29/2007 | US20070072294 Use of human stem cells and/or factors they produce to promote adult mammalian cardiac repair through cardiomyocyte cell division | 
| 03/29/2007 | US20070072293 Process for stabilization of bacterial cells | 
| 03/29/2007 | US20070072292 EphA4-positive human adult pancreatic endocrine progenitor cells | 
| 03/29/2007 | US20070072291 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use | 
| 03/29/2007 | US20070072289 Application apparatus of 3-dimensional klinostat and growing method using the same | 
| 03/29/2007 | US20070072282 Bovine adeno-associated viral (baav) vector and uses thereof | 
| 03/29/2007 | US20070072263 DNA19355 polypeptide, a tumor necrosis factor homolog | 
| 03/29/2007 | US20070072261 Nucleic acids encoding PAK5 polypeptidesm and methods of use thereof | 
| 03/29/2007 | US20070072252 Method for the in vitro titration of an ncta application thereof in a method for the evaluation and/or monitoring of a biological product production method | 
| 03/29/2007 | US20070072246 Cell-based assays for determining drug action | 
| 03/29/2007 | US20070072239 Pharmaceutical compositions and methods of using secreted frizzled related protein | 
| 03/29/2007 | US20070072232 Identification of genetic components of drug response | 
| 03/29/2007 | US20070072225 Antibodies with simultaneous subsite specificities to protein and lipid epitopes | 
| 03/29/2007 | US20070072172 Liver specific chimeric regulatory sequence and use thereof | 
| 03/29/2007 | US20070072171 Solid surface for biomolecule delivery and high-throughput assay | 
| 03/29/2007 | US20070071829 Universally applicable virus inactivated blood plasma produced from portions of non-caucasian plasma | 
| 03/29/2007 | US20070071774 Protein D - an IgD-binding protein of Haemophilus influenzae | 
| 03/29/2007 | US20070071770 Recombinant MVA virus, and the use thereof | 
| 03/29/2007 | US20070071769 Recombinant MVA virus, and the use thereof | 
| 03/29/2007 | US20070071765 Compositions for Immunotherapy and Uses Thereof | 
| 03/29/2007 | US20070071759 Antibody-immune cell ligand fusion protein for cancer therapy | 
| 03/29/2007 | US20070071752 Sphingosine kinase enzyme | 
| 03/29/2007 | US20070071744 Agents which bind to epitopes of glycoprotein VI | 
| 03/29/2007 | US20070071743 Novel human cell surface protein with immunoglobulin folds, BGS-19 | 
| 03/29/2007 | US20070071742 bind ICAM-1 and inhibit pathogen infection of cells expressing ICAM-1; for protection against human rhinovirus (HRV), coxackie A virus, respiratory syncytial virus (RSV), or malaria | 
| 03/29/2007 | US20070071736 Propagating stem cells in growth factor mixture at preferential site in heart; tissue engineering; regenerative medicine | 
| 03/29/2007 | US20070071735 Propagating stem cells in growth factor mixture at preferential site in heart; tissue engineering; regenerative medicine | 
| 03/29/2007 | US20070071733 Synthetic substrate for tissue formation | 
| 03/29/2007 | US20070071732 Secretory cell-containing macrobeads comprising seakem gold agarose, and uses thereof | 
| 03/29/2007 | US20070071730 Stem cells of the islets of langerhans and their use in treating diabetes mellitus | 
| 03/29/2007 | US20070071727 Melanocytes in therapy of neurodegenerative diseases | 
| 03/29/2007 | US20070071714 Stem cell factor | 
| 03/29/2007 | US20070071675 Engineered multivalent and multispecific binding proteins; treatment of acute and chronic inflammatory, cancer | 
| 03/29/2007 | DE102005046225A1 Cell culture medium, useful for e.g. cultivating cell culture, comprises a substance of succinic-, maleic-, alpha-keto glutaric-, fumaric-, oxaloacetic-, isocitronic-, oxalosuccinic-, tartaric-, adipic- and/or latic- acid | 
| 03/29/2007 | DE10106163B4 Verfahren zur Herstellung von Kohlenhydraten A process for producing carbohydrates | 
| 03/29/2007 | CA2812343A1 Methods for genetic control of insect infestations in plants and compositions thereof | 
| 03/29/2007 | CA2800945A1 Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration | 
| 03/29/2007 | CA2663412A1 Compositions and methods for the augmentation and repair of defects in tissue | 
| 03/29/2007 | CA2623170A1 Kit for preparing a composition comprising fat cells | 
| 03/29/2007 | CA2623153A1 The use of sirnas in organ storage/reperfusion solutions | 
| 03/29/2007 | CA2623106A1 Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof | 
| 03/29/2007 | CA2623102A1 Plant extract and use thereof as a cryoprotective agent | 
| 03/29/2007 | CA2622916A1 Method for obtaining human smooth muscular cells and uses thereof | 
| 03/29/2007 | CA2621380A1 Methods for rapidly and accurately locating avian egg blastoderms | 
| 03/29/2007 | CA2621026A1 Cell migration assay | 
| 03/29/2007 | CA2617930A1 Transgenic ungulates expressing ctla4-ig and uses thereof | 
| 03/28/2007 | EP1767639A1 Oral vaccine against protozoiasis using genetically modified plant | 
| 03/28/2007 | EP1767638A2 Mutation associated with epilepsy | 
| 03/28/2007 | EP1767637A1 Mutation associated with epilepsy | 
| 03/28/2007 | EP1767636A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use | 
| 03/28/2007 | EP1767634A1 Novel galectin 8 modification protein and use thereof | 
| 03/28/2007 | EP1767633A1 Novel polypeptide useful for diagnosis and treatment of cancer | 
| 03/28/2007 | EP1767632A2 A method for local administration of synthetic double-stranded oligonucleotides targeting a VEGF receptor | 
| 03/28/2007 | EP1767629A2 Methods for the detection, analysis and isolation of nascent proteins | 
| 03/28/2007 | EP1767627A1 Anti-perp antibody | 
| 03/28/2007 | EP1767625A1 Activity regulator for interferon producing cell | 
| 03/28/2007 | EP1767624A1 Improved nitrile hydratase | 
| 03/28/2007 | EP1767622A1 Plasmid responsive to dioxin, etc., transgenic cell for assay of dioxin, etc. and utilizing the same, dioxin, etc. detecting method and biosensor | 
| 03/28/2007 | EP1767620A1 Exhaustive gene expression profiling analysis using microsample | 
| 03/28/2007 | EP1767619A1 Method of culturing embryonic stem cells with the use of amniotic membrane-origin factor | 
| 03/28/2007 | EP1767618A1 Induction of insulin secreting cell | 
| 03/28/2007 | EP1767617A1 Mesenchymal stem cells isolation and expansion method and uses thereof | 
| 03/28/2007 | EP1767546A1 Angiogenesis-inhibiting chimeric protein and the use | 
| 03/28/2007 | EP1767544A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2 | 
| 03/28/2007 | EP1767543A1 Novel bee venom polypeptides and methods of use thereof | 
| 03/28/2007 | EP1767541A1 Hla-a24- or hla-a2-binding peptide of parathyroid hormone-related protein |